Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/EQL-PHARMA-AB-120970591/noticia/EQL-Pharma-otorga-la-licencia-de-Mellozzan-a-H-A-C-Pharma-para-el-TDAH-40427475/?utm_source=whatsapp&utm_medium=social&utm_campaign=share